[1] Li M M, Dal Maso L, Vaccarella S. Global trends in thyroid cancer incidence and the impact of overdiagnosis[J]. The Lancet Diabetes & Endocrinology, 2020, 8(6):468-470. [2] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA:a Cancer Journal for Clinicians, 2018, 68(6):394-424. [3] Davies L, Hoang J K. Thyroid cancer in the USA:Current trends and outstanding questions[J]. The Lancet. Diabetes & Endocrinology, 2021, 9(1):11-12. [4] Boye K, Melandsmo G M. S100A4 and metastasis:A small actor playing many roles[J]. The American Journal of Pathology, 2010, 176(2):528-535. [5] Mishra S K, Siddique H R, Saleem M. S100A4 calcium-binding protein is key player in tumor progression and metastasis:Preclinical and clinical evidence[J]. Cancer Metastasis Reviews, 2012, 31(1-2):163-172. [6] Fei F, Qu J, Zhang M Q, et al. S100A4 in cancer progression and metastasis:A systematic review[J]. Oncotarget, 2017, 8(42):73219-73239. [7] Zhang K, Yu M, Hao F, et al. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo[J]. Cancer Biomarkers, 2016, 17(3):281-291. [8] Medapati M R, Dahlmann M, Ghavami S, et al. RAGE mediates the pro-migratory response of extracellular S100A4 in human thyroid cancer cells[J]. Thyroid:Official Journal of the American Thyroid Association, 2015, 25(5):514-527. [9] 陈立斌, 许幼峰, 曹涌, 等. 超声弹性成像诊断甲状腺肿块的价值及影响因素分析[J]. 中国临床医学影像杂志, 2010, 21(4):268-270. [10] Moon H J, Sung J M, Kim E K, et al. Diagnostic performance of gray-scale US and elastography in solid thyroid nodules[J]. Radiology, 2012, 262(3):1002-1013. [11] 徐林霞, 王素萍, 徐国霞, 等. 超声弹性成像参数联合血清MK和VEGF对分化型甲状腺癌的诊断价值及与肿瘤恶性程度关系研究[J]. 影像科学与光化学, 2021, 39(1):12-18. [12] 陈沛芬, 赖瑾瑜, 陈俊君. 超声弹性成像参数与血浆miR-663、miR-221诊断乳头状甲状腺癌的价值及其病理学基础分析[J]. 山东医药, 2021, 61(17):78-81. [13] Ito Y, Yoshida H, Tomoda C, et al. S100A4 expression is an early event of papillary carcinoma of the thyroid[J]. Oncology, 2004, 67(5-6):397-402. [14] Cheon M G, Son Y W, Lee J H, et al. Mts1 up-regulation is associated with aggressive pathological features in thyroid cancer[J]. Cancer Genomics & Proteomics, 2019, 16(5):369-376. [15] 武秀娟. 超声弹性成像结合血清MicroRNA表达对甲状腺癌侵袭性的研究[D]. 呼和浩特:内蒙古医科大学, 2016. [16] Lyshchik A, Higashi T, Asato R, et al. Cervical lymph node metastases:Diagnosis at sonoelastography - initial experience[J]. Radiology, 2007, 243(1):258-267. [17] Zou M J, Famulski K S, Parhar R S, et al. Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis:Identification of S100A4(Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma[J]. The Journal of Clinical Endocrinology and Metabolism, 2004, 89(12):6146-6154. [18] Min H S, Choe G, Kim S W, et al. S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid[J]. Modern Pathology, 2008, 21(6):748-755. [19] Jia W, Gao X J, Zhang Z D, et al. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF[J]. European Review for Medical and Pharmacological Sciences, 2013, 17(11):1495-1508. |